The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic

S Broder - Antiviral research, 2010 - Elsevier
In the last 25 years, HIV-1, the retrovirus responsible for the acquired immunodeficiency
syndrome (AIDS), has gone from being an “inherently untreatable” infectious agent to one …

[HTML][HTML] Genome-wide association studies in ADHD

B Franke, BM Neale, SV Faraone - Human genetics, 2009 - Springer
Attention-deficit/hyperactivity disorder, ADHD, is a common and highly heritable
neuropsychiatric disorder that is seen in children and adults. Although heritability is …

Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants

S Sayols-Baixeras, C Lluís-Ganella… - The application of …, 2014 - Taylor & Francis
Coronary artery disease (CAD) is the leading cause of death and disability worldwide, and
its prevalence is expected to increase in the coming years. CAD events are caused by the …

How do we improve patient compliance and adherence to long-term statin therapy?

P Maningat, BR Gordon, JL Breslow - Current atherosclerosis reports, 2013 - Springer
Statins are highly effective drugs prescribed to millions of people to lower LDL-cholesterol
and decrease cardiovascular risk. The benefits of statin therapy seen in randomized clinical …

A network view of disease and compound screening

EE Schadt, SH Friend, DA Shaywitz - Nature reviews Drug discovery, 2009 - nature.com
The large-scale generation and integration of genomic, proteomic, signalling and
metabolomic data are increasingly allowing the construction of complex networks that …

[图书][B] The handbook of biomarkers

KK Jain, KK Jain - 2010 - Springer
There are several definitions of biomarkers. A biomarker is a characteristic that can be
objectively measured and evaluated as an indicator of a physiological as well as a …

Pharmacogenetics and cardiovascular disease—implications for personalized medicine

JA Johnson, LH Cavallari - Pharmacological reviews, 2013 - ASPET
The past decade has seen tremendous advances in our understanding of the genetic factors
influencing response to a variety of drugs, including those targeted at treatment of …

The microeconomics of personalized medicine: today's challenge and tomorrow's promise

JC Davis, L Furstenthal, AA Desai, T Norris… - Nature reviews Drug …, 2009 - nature.com
Abstract'Personalized medicine'promises to increase the quality of clinical care and, in some
cases, decrease health-care costs. Despite this, only a handful of diagnostic tests have …

Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study

D Shiffman, ES O'Meara, LA Bare… - … , and vascular biology, 2008 - Am Heart Assoc
Objective—We asked whether single nucleotide polymorphisms (SNPs) that had been
nominally associated with cardiovascular disease in antecedent studies were also …

[HTML][HTML] Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp (a)

HA Deshmukh, HM Colhoun, T Johnson… - Journal of lipid …, 2012 - ASBMB
We carried out a genome-wide association study (GWAS) of LDL-c response to statin using
data from participants in the Collaborative Atorvastatin Diabetes Study (CARDS; n= 1,156) …